Weekly Digest – January 2026 Weekly Digest – January 2026 7 January 2026: Lonza’s Synaffix and Sidewinder Therapeutics announce multi-target License agreement to advance development of next generation Bispecific ADCs Lonza (through its subsidiary Synaffix) and Sidewinder Therapeutics entered a […]
Weekly Digest – January 2026 Weekly Digest – January 2026 7 January 2026: InduPro Therapeutics announces strategic collaboration with Lilly to develop first-in-class Bispecific/Multispecific oncology therapeutics using InduPro’s proximity-guided platform InduPro entered a global strategic collaboration, licensing agreement, and equity […]
Weekly Digest – January 2026 Weekly Digest – January 2026 6 January 2026: Convergent Therapeutics and NorthStar Medical Radioisotopes announce expanded partnership to support Convergent’s late-stage alpha-emitting radioantibody program Convergent Therapeutics and NorthStar Medical Radioisotopes expanded their partnership to co-locate […]
